rs754267693
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_152564.5(VPS13B):c.4772G>A(p.Arg1591Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000292 in 1,612,308 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_152564.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VPS13B | ENST00000358544.7 | c.4847G>A | p.Arg1616Gln | missense_variant | Exon 31 of 62 | 1 | NM_017890.5 | ENSP00000351346.2 | ||
VPS13B | ENST00000357162.7 | c.4772G>A | p.Arg1591Gln | missense_variant | Exon 31 of 62 | 1 | NM_152564.5 | ENSP00000349685.2 |
Frequencies
GnomAD3 genomes AF: 0.0000330 AC: 5AN: 151646Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000360 AC: 9AN: 250258Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135276
GnomAD4 exome AF: 0.0000288 AC: 42AN: 1460662Hom.: 0 Cov.: 32 AF XY: 0.0000289 AC XY: 21AN XY: 726642
GnomAD4 genome AF: 0.0000330 AC: 5AN: 151646Hom.: 0 Cov.: 32 AF XY: 0.0000541 AC XY: 4AN XY: 74004
ClinVar
Submissions by phenotype
Cohen syndrome Uncertain:2
- -
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1616 of the VPS13B protein (p.Arg1616Gln). This variant is present in population databases (rs754267693, gnomAD 0.008%). This variant has not been reported in the literature in individuals affected with VPS13B-related conditions. ClinVar contains an entry for this variant (Variation ID: 528840). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on VPS13B protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
VPS13B-related disorder Uncertain:1
The VPS13B c.4772G>A variant is predicted to result in the amino acid substitution p.Arg1591Gln. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0062% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/8-100568704-G-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at